α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence-Reference-Cited by-同舟云学术

α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence

Published:2022-01 Issue: Volume:201 Page:111617
ISSN:0047-6374
Container-title:Mechanisms of Ageing and Development
language:en
Short-container-title:Mechanisms of Ageing and Development

Author:

Serna-Salas Sandra A.^ORCID,Arroyave-Ospina Johanna C.^ORCID,Zhang Mengfan,Damba Turtushikh^ORCID,Buist-Homan Manon,Muñoz-Ortega Martin H.,Ventura-Juárez Javier^ORCID,Moshage Han

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Elsevier BV

Subject

Developmental Biology,Aging

Reference39 articles.

1. Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements;Al-Haj;Nucleic Acids Res.,2012

2. Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury;Aoshiba;Exp. Toxicol. Pathol.,2013

3. Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway;Chen;Sci. Rep.,2016

4. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor;Coppé;PLoS Biol.,2008

5. The Senescence-Associated Secretory: the dark side of tumor suppression;Coppé;Annu. Rev. Pathol.,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aerosolized ⍺₁adrenoreceptor antagonism does not affect experimentally induced lung fibrosis in animal models;2023-12-14

2. Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome;Metabolites;2023-11-03

3. Targeting Hepatic Stellate Cell Death to Reverse Hepatic Fibrosis;Current Drug Targets;2023-05

4. Hypertension and cellular senescence;Biogerontology;2023-04-03

5. Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity;Annals of Medicine;2023-02-24